SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-21-237974
Filing Date
2021-08-05
Accepted
2021-08-06 14:30:50
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-3 d208756df3.htm F-3 458954
2 EX-4.4 d208756dex44.htm EX-4.4 305459
3 EX-4.6 d208756dex46.htm EX-4.6 96600
4 EX-4.7 d208756dex47.htm EX-4.7 86150
5 EX-5.1 d208756dex51.htm EX-5.1 75009
6 EX-5.2 d208756dex52.htm EX-5.2 21891
7 EX-23.1 d208756dex231.htm EX-23.1 1615
8 GRAPHIC g208756g0728231911184.jpg GRAPHIC 4032
9 GRAPHIC g208756g0728231911402.jpg GRAPHIC 19882
10 GRAPHIC g208756g0804001138384.jpg GRAPHIC 2308
11 GRAPHIC g208756g0804193855264.jpg GRAPHIC 2413
  Complete submission text file 0001193125-21-237974.txt   1086888
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-258556 | Film No.: 211152378
SIC: 2836 Biological Products, (No Diagnostic Substances)